High Density Lipoproteins and Type 2 Inflammatory Biomarkers are Negatively Correlated in Atopic Asthmatics

Amisha V. Barochia1 , Elizabeth M. Gordon1 , Maryann Kaler1 , Rosemarie A. Cuento1 , Patricia Theard1 , Debbie M. Figueroa1 , Xianglan Yao1 , Nargues A. Weir1 , Maureen L. Sampson2 , Mario Stylianou3 , David F. Choy4 , Cecile T.J. Holweg4 , Alan T. Remaley5 , and Stewart J. Levine1

Abstract

Blood eosinophil counts and serum periostin levels are biomarkers of type 2 inflammation. Although serum levels of HDL (high-density lipoprotein) and apolipoprotein A-I have been associated with less severe airflow obstruction in asthma, it is not known whether serum lipids or lipoprotein particles are correlated with type 2 inflammation in asthmatics. Here, we assessed whether serum lipids and lipoproteins correlated with blood eosinophil counts or serum periostin levels in 165 atopic asthmatics, and 163 non-asthmatic subjects with and without atopy. Serum lipids and lipoproteins were quantified using standard laboratory assays and nuclear magnetic resonance (NMR) spectroscopy. Absolute blood eosinophils were quantified by complete blood counts. Periostin levels were measured using the Elecsys Periostin assay. In atopic asthmatics, blood eosinophils negatively correlated with serum HDL-cholesterol and total HDL particles measured by NMR spectroscopy (HDLNMR). Serum periostin levels negatively correlated with total HDLNMR. In contrast, blood eosinophil counts positively correlated with serum triglyceride levels. This study demonstrates for the first time that HDL particles were negatively correlated, whereas serum triglycerides were positively correlated, with blood eosinophils in atopic asthmatics. This supports the concept that serum levels of HDL and triglycerides may be linked to systemic type 2 inflammation in atopic asthma.

Full Text (PDF) Free

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @worldallergy: The AAAAI/WAO Joint Congress is only 1 week away. Be sure to follow #AAAAIWAO18 to hear about all the latest research in…
2hreplyretweetfavorite
Interasma RT @Aller_MD: Study: Researchers Retrained Immune Systems of Mice to Switch Off Anaphylaxis https://t.co/NEjS1hZxDt https://t.co/GixFWhWvoC
3hreplyretweetfavorite
Interasma RT @Aller_MD: Integration of eHealth Tools in the Process of Workplace Health Promotion: Proposal for Design and Implementation https://t.c…
3hreplyretweetfavorite
Interasma RT @Aller_MD: Aimmune's Peanut Allergy Drug Meets Main Goal, Shares Surge https://t.co/cSVVr9Cm48 https://t.co/OQZVlq8Wfx
3hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: EUFOREA on Twitter: "The EU summit 2018 on #mhealth, air pollution &… https://t.co/yZWlx0YgdD, see more https://t.…
3hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma